Trials of endovascular therapies or collaterals?

International Journal of Stroke

Volumn 8, Issue 4, 2013, Pages 258-259

  Liebeskind, David S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute ischemia; Collateral circulation; Endovascular; Hemodynamics; Stroke

Indexed keywords

ARTICLE; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DEVICE THERAPY; ENDOVASCULAR THERAPY; HUMAN; MECHANICAL THROMBECTOMY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

BRAIN ISCHEMIA; CEREBRAL REVASCULARIZATION; CLINICAL TRIALS AS TOPIC; COLLATERAL CIRCULATION; ENDOVASCULAR PROCEDURES; FIBRINOLYTIC AGENTS; HUMANS; STROKE; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 84878179141     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/ijs.12090     Document Type: Article

References (7)

1. Kidwell CS, Jahan R, Gornbein J etal. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013; 368:914-923.
2. Broderick JP, Palesch YY, Demchuk AM etal. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013; 368:893-903.
3. Nogueira RG, Lutsep HL, Gupta R etal. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 2012; 380:1231-1240.
4. Saver JL, Jahan R, Levy EI etal. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012; 380:1241-1249.
5. Liebeskind DS, Tomsick TA, Yeatts S etal. Collaterals in the Interventional Management of Stroke (IMS) III trial. Stroke 2013; 44:AWP5.
6. Liebeskind DS, Jahan R, Nogueira RG, Zaidat OO, Saver JL, Investigators ftS. Impact of collaterals on successful revascularization in SWIFT. Stroke 2013; 44:A57.
7. Liebeskind DS, Sanossian N, Jovin TG etal. Collateral flow and ASPECTS of infarct evolution dominate time to reperfusion in outcomes of TREVO2. Stroke 2013; 44:A167.